Metixene
Metixene (brand names Methixart, CholinFall, Tremonil, Trest), also known as methixene, is an anticholinergic used as an Management of Parkinson's disease#Medication}antiparkinsonian agent.
 | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| ATC code |
|
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.023.282  |
| Chemical and physical data | |
| Formula | C20H23NS |
| Molar mass | 309.47 g·mol−1 |
  | |
References
Antiparkinson agents (N04) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dopaminergics |
| ||||||||||
| Anticholinergics |
| ||||||||||
| Others |
| ||||||||||
| |||||||||||
Muscarinic acetylcholine receptor modulators | |||||
|---|---|---|---|---|---|
| mAChRs |
| ||||
| Precursors (and prodrugs) |
| ||||
See also: Receptor/signaling modulators • Nicotinic acetylcholine receptor modulators • Acetylcholine metabolism/transport modulators | |||||